Dermatological therapeutics market is being driven by the increase in incidence rates of dermatology diseases, increase in awareness levels of disease progression and etiology and increase in the elderly population. According to the WHO, skin diseases in developing countries has become a serious impact on people’s quality of life, causing productivity lost at work and other places, and discrimination due to disfigurement. Skin changes may also indicate the presence of more serious skin disorders that require treatment. According to theWorld Allergy Organization 2018 fact sheet, globally between 5-30% of the pediatric and 1- 10% of the adult population have atopic dermatitis. According to World Population Prospects 2019 report (United Nations, 2019), there were about 703 million people aged 65 years or over in the world in 2019. The number of elderly population is projected to double to 1.5 billion in 2050. Worldwide, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019.Moreover, by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. As the number of elderly population is expected to grow worldwide and this population are more prone to dermatological disorders which drives the market in near future.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6.COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS